CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Our treatments offer promise for people in more than 100 countries living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
Booth: 201
DAWN AC software supports the management of anticoagulation services across North America, the UK and around the world. The software includes VKA Induction, Maintenance, Bridging and DOAC workflows to deliver a reliable, customer specific solution that increases patient safety, facilitates healthcare professional productivity and improves quality of care.
Booth: 102
Provider Prescribed INR Patient Self-Testing.
Enables patients to test their INR from the comfort of their own home with support by the leading provider of INR self-testing services in the US.
Booth: 302
Aniara Diagnostica, Inc. provides a comprehensive offering of diagnostic and research agents, as well as screening tools, all designed to meet today’s highest standards in terms of product quality. You can also rely on Aniara for cost-effective delivery and around-the-clock customer service.
Aniara distributes diagnostic and research reagents to various customers, including hospital labs, research facilities, and industrial clients. We offer a full range of DOACs, including bivalirudin, as well as an Anti-IIa assay for DOAC to UFH transfer. Aniara also provides a state-of-the-art HIT assay, and a full range of factor assays including FVIII and FIX. It is our mission to shape the future with innovative solutions. To help obtain this goal and support other innovators, Aniara offers a Research Discount for academic exploration and two annual Aniara Grants focused on forward-thinking coagulation/hematology research.
Booth: 101
At Anthos, we are committed to pushing the boundaries of innovation in cardiovascular medicine, addressing critical unmet needs in vulnerable populations, and striving for unparalleled excellence across all aspects of our work. Our immediate goal is to establish a new benchmark in anticoagulation treatment to improve the lives of patients worldwide.
Booth: 104
BleedCEASE is the quick and easy way to stop bleeding, both nosebleeds and topical bleeding, regardless of the cause.BleedCEASE is an approved medical device for OTC sale. BleedCEASE is equally effective for nosebleeds and topical bleeds and is the only quality stop bleeding product costing less than a dollar per use.
Booth: 305
iLine Microsystems is a biotech company with over 10 years of experience in designing innovative and precise IVD Point-of-Care devices, specializing in the field of hemostasis.
Booth: 303
Inovalon is a leading provider of cloud-based SaaS solutions empowering data-driven healthcare. The Inovalon ONE® Platform brings together national-scale connectivity, real-time primary source data access, and advanced analytics to enable improved clinical outcomes and economics across the healthcare ecosystem. For more information, visit www.inovalon.com
Booth: 203
InsightRX maximizes therapeutic success through precision medicine applications, empowering both provider healthcare and life science organizations to individualize treatment from clinical development to the point of care. Our anticoagulation CDS modules help improve target attainment, ease clinician burden, and support data visualization, all powered by continuous learning and AI.
Booth: 301
mdINR, offers patients and medical providers a comprehensive home INR monitoring program that can help improve health outcomes. It’s our mission to improve the health-related quality of life of your patients by providing a home INR self-testing program that is easy for patients to self-test from home.
Booth: 304
Perosphere is a private medical device company founded in 2017, providing innovative coagulation diagnostics that address critical unmet needs at the point of care. Our mission is to positively impact patient outcomes and enable more informed treatment decisions through quick measurement of coagulation status.
Booth: 202
Xprecia Prime™ is the new and improved generation of portable coagulation monitoring device. Xprecia Prime™ is small, accurate, and easy to use. This new coagulation analyzer is designed for fast and reliable PT/INR testing, allowing medical practitioners to monitor vitamin K antagonist oral anticoagulation therapy (e.g. Warfarin, Coumadin etc.) at the point of care (POC), primary care, urgent care, and hospitals. It should not be used to measure PT/INR in patients on other anticoagulation therapies. Xprecia Prime™ meets the modern high-quality POC coagulation testing requirements, providing PT/INR results comparable to laboratory analysis in under a minute.
Booth: 103
MAQI2 seeks to improve the safety, quality of care and outcomes of patients requiring anticoagulation.
Global Thrombosis Forum is a non-profit organization that is invloved in increasing and spreading the awareness of thrombosis in the cummunities Worldwide. GTF also coaches its high school scholars in conducting research, making presentations of their research at Scientific Society Meetings and publishing their research in peer-reviewed journals.
Today, the ISTH is the leading thrombosis- and hemostasis-related professional organization in the world with more than 7,700 members in +110 countries.
The National Blood Clot Alliance is the nation's leading nonprofit voluntary health organization dedicated to advancing the prevention, early diagnosis and successful treatment of life-threatening blood clots such as deep vein thrombosis and pulmonary embolism. Each year NBCA serves more than 3 million people with blood clot-related information, resources, and support.
The National Certification Board for Anticoagulation Providers (NCBAP) sponsors the Board Examination that validates clinicians as Certified Anticoagulation Care Providers (CACP). CACP clinicians are board-certified, demonstrating specialized knowledge and skills in antithrombotic therapy. Organizations seeking designation as an Anticoagulation Center of Excellence (ACF) must have a CACP clinician on staff.
The PERT Consortium™ is the premier organization dedicated to establishing, optimizing, and expanding multidisciplinary Pulmonary Embolism Response Teams (PERT), and their quality care for PE patients.
